Princeton Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $232K | Sell |
9,620
-637
| -6% | -$16.7K | 0.05% | 136 |
|
|
2026
Q1 | $288K | Buy |
10,257
+437
| +4% | +$11.6K | 0.08% | 113 |
|
|
2025
Q4 | $245K | Hold |
9,820
| – | – | 0.06% | 130 |
|
|
2025
Q3 | $250K | Buy |
+9,820
| New | +$242K | 0.07% | 123 |
|
|
2024
Q4 | – | Sell |
-7,108
| Closed | -$206K | – | 128 |
|
|
2024
Q3 | $206K | Sell |
7,108
-9,582
| -57% | -$280K | 0.06% | 105 |
|
|
2024
Q2 | $467K | Sell |
16,690
-895
| -5% | -$24.6K | 0.15% | 58 |
|
|
2024
Q1 | $488K | Sell |
17,585
-872
| -5% | -$24.2K | 0.18% | 60 |
|
|
2023
Q4 | $531K | Sell |
18,457
-2,634
| -12% | -$79.6K | 0.21% | 59 |
|
|
2023
Q3 | $700K | Sell |
21,091
-35,692
| -63% | -$1.26M | 0.32% | 55 |
|
|
2023
Q2 | $2.08M | Sell |
56,783
-3,619
| -6% | -$141K | 0.86% | 29 |
|
|
2023
Q1 | $2.46M | Sell |
60,402
-7,354
| -11% | -$318K | 1.06% | 27 |
|
|
2022
Q4 | $3.47M | Sell |
67,756
-8,411
| -11% | -$403K | 1.54% | 22 |
|
|
2022
Q3 | $3.33M | Sell |
76,167
-228
| -0.3% | -$11.1K | 1.46% | 22 |
|
|
2022
Q2 | $4M | Buy |
76,395
+1,457
| +2% | +$74.2K | 1.55% | 18 |
|
|
2022
Q1 | $3.88M | Sell |
74,938
-117
| -0.2% | -$6.07K | 1.21% | 24 |
|
|
2021
Q4 | $4.43M | Sell |
75,055
-8
| -0% | -$396 | 1.27% | 23 |
|
|
2021
Q3 | $3.23M | Buy |
75,063
+706
| +0.9% | +$31.3K | 1.03% | 31 |
|
|
2021
Q2 | $2.91M | Buy |
74,357
+2,399
| +3% | +$93.3K | 0.9% | 36 |
|
|
2021
Q1 | $2.61M | Sell |
71,958
-2,003
| -3% | -$71.1K | 0.88% | 34 |
|
|
2020
Q4 | $2.72M | Sell |
73,961
-708
| -0.9% | -$26K | 0.97% | 31 |
|
|
2020
Q3 | $2.6M | Buy |
74,669
+3,039
| +4% | +$107K | 1.05% | 31 |
|
|
2020
Q2 | $2.22M | Sell |
71,630
-2,478
| -3% | -$84.2K | 0.99% | 30 |
|
|
2020
Q1 | $2.71M | Sell |
74,108
-3,305
| -4% | -$113K | 1.41% | 23 |
|
|
2019
Q4 | $2.79M | Buy |
77,413
+724
| +0.9% | +$25.8K | 1.25% | 27 |
|
|
2019
Q3 | $2.61M | Sell |
76,689
-883
| -1% | -$32.1K | 1.27% | 27 |
|
|
2019
Q2 | $3.19M | Sell |
77,572
-3,456
| -4% | -$137K | 1.55% | 22 |
|
|
2019
Q1 | $3.27M | Sell |
81,028
-20,608
| -20% | -$825K | 1.65% | 20 |
|
|
2018
Q4 | $4.21M | Sell |
101,636
-38,725
| -28% | -$1.61M | 2.46% | 14 |
|
|
2018
Q3 | $5.87M | Sell |
140,361
-7,513
| -5% | -$289K | 2.44% | 14 |
|
|
2018
Q2 | $5.09M | Sell |
147,874
-1,484
| -1% | -$50.7K | 2.21% | 18 |
|
|
2018
Q1 | $5.03M | Sell |
149,358
-7,101
| -5% | -$244K | 2.23% | 18 |
|
|
2017
Q4 | $5.38M | Buy |
+156,459
| New | +$5.33M | 2.4% | 16 |
|
|
2016
Q4 | $477K | Sell |
15,465
-341
| -2% | -$10.4K | 0.69% | 62 |
|
|
2016
Q3 | $508K | Buy |
15,806
+1,387
| +10% | +$46.4K | 0.63% | 58 |
|
|
2016
Q2 | $482K | Buy |
14,419
+2,256
| +19% | +$72K | 0.55% | 57 |
|
|
2016
Q1 | $342K | Buy |
+12,163
| New | +$347K | 0.39% | 65 |
|
Other funds holding PFE
Princeton Capital Management's PFE Position: Q2 2026 in Review
Princeton Capital Management reduced its Pfizer (PFE) stake by 6.2% in Q2 2026, selling an estimated $16.7K and leaving 9,620 shares worth $232K. The position accounts for 0.05% of the portfolio, ranked #136.
Princeton Capital Management first reported a position in PFE in Q1 2016 and has held it in 36 quarters since. The position peaked at $5.87M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Princeton Capital Management held 9,620 shares of Pfizer worth $232K as of Q2 2026.
- Princeton Capital Management sold 637 Pfizer shares in Q2 2026, an estimated $16.7K.
- Pfizer made up 0.05% of Princeton Capital Management's portfolio in Q2 2026, its #136 holding.
- Princeton Capital Management first reported a position in Pfizer in Q1 2016 and has held it in 36 quarters since.
- Princeton Capital Management's Pfizer position peaked at $5.87M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Princeton Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.